Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB668668,5-2,12
PKN64,7664,88-5,48
Msft0,13
Nokia4,68054,83851,20
IBM-0,33
Mercedes-Benz Group AG64,2464,27-0,11
PFE-0,33
03.12.2022 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 02.12.2022 21:59:59
Quest Diagnostcs (DGX, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
150,45 -1,42 -2,16 1 269 427
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 03.12.2022
Popis společnosti
Obecné informace
Název společnostiQuest Diagnostics Inc
TickerDGX
Kmenové akcie:Ordinary Shares
RICDGX
ISIN-
Prioritní akciePreference Shares
Poslední známé roční výsledky31.12.2021
Poslední známé čtvrtletní výsledky30.09.2022
Počet zaměstnanců k 31.12.2021 40 000
Akcie v oběhu k 14.10.2022 113 887 466
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice500 Plaza Drive
MěstoSECAUCUS
PSČ07094
ZeměUnited States
Kontatní osobaShawn Bevec
Funkce kontaktní osobyVice President - Investor Relations
Telefon19 735 202 700
Fax13026555049
Kontatní telefon19 735 202 900

Business Summary: Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through the DIS segment, which provides diagnostic information services to a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers, accountable care organizations (ACOs) and direct contract entities (DCEs). It is also engaged in two business operations, Diagnostic Information Services, which develops and delivers diagnostic information services that provide insights to a range of customers, and the Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company’s services primarily are provided under the Quest Diagnostics brand. The Company is also engaged in providing outreach laboratory services business.
Financial Summary: BRIEF: For the nine months ended 30 September 2022, Quest Diagnostics Inc revenues decreased 6% to $7.55B. Net income applicable to common stockholders decreased 47% to $841M. Revenues reflect DIS business segment decrease of 6% to $7.34B, All other operating segments decrease of 8% to $206M. Net income also reflects DIS business segment income decrease of 29% to $1.45B, All other operating segments income decrease of 38% to $16M.
Odvětvová klasifikace
TRBC2009Healthcare Facilities / Services
TRBC2012Healthcare Facilities & Services (NEC)
RBSS2004Healthcare Facilities
MGINDUSTRYHealthcare Facilities
MGSECTORHealthcare
NAICSMedical Laboratories
NAICS2007Medical Laboratories
NAICS1997Medical Laboratories
SICMedical Laboratories
SICMedical Laboratories



  • Poslední aktualizace: 03.12.2022
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Chairman of the BoardStephen Rusckowski6401.11.202201.05.2012
President, Chief Executive Officer, DirectorJames Davis5901.11.202216.04.2013
Chief Financial Officer, Executive Vice PresidentSam Samad5325.07.202211.07.2022
Senior Vice President, General CounselMichael Prevoznik60
Senior Vice President, Chief Commercial OfficerMark Delaney-20.04.202220.04.2022
Senior Vice President - Regional BusinessesCatherine Doherty5920.04.2022
Senior Vice President - Molecular Genomics & OncologyMark Gardner-
Senior Vice President - Clinical SolutionsKarthik Kuppusamy-
Senior Vice President - Advanced and General Diagnostics Clinical SolutionsCarrie Manner4820.04.2022
Senior Vice President - Diagnostic ServicesPatrick Plewman-20.04.202220.04.2022